Activated protein C to heal pressure ulcers

International Wound Journal

Volumn 13, Issue 5, 2016, Pages 986-991

  Wijewardena, Aruna ^a   Lajevardi, Sepehr S ^a   Vandervord, Elle ^a   Vandervord, John ^a   Lang, Thomas C ^b   Fulcher, Gregory ^b   Jackson, Christopher J ^b  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Activated protein C; Chronic; Pressure ulcer; Topical negative pressure; Wound

Indexed keywords

FIBRINOLYTIC AGENT; PROTEIN C;

ADULT; CASE REPORT; CHRONIC DISEASE; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; FEMALE; HUMAN; MALE; PRESSURE ULCER; TREATMENT OUTCOME; VACUUM ASSISTED CLOSURE; WOUND HEALING;

ADULT; CHRONIC DISEASE; DOUBLE-BLIND METHOD; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; NEGATIVE-PRESSURE WOUND THERAPY; PRESSURE ULCER; PROTEIN C; TREATMENT OUTCOME; WOUND HEALING;

EID: 84906803228     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/IWJ.12343     Document Type: Article

References (25)

1. Meehan M. Multisite pressure ulcer prevalence survey. Decubitus 1990;3:14–7.
2. Berlowitz DR, Wilking SV. The short-term outcome of pressure sores. J Am Geriatr Soc 1990;38:748–52.
3. Ditunno JF, Formal CS. Chronic Spinal Cord Injury. NEnglJMed 1994;330:550–6.
4. Bergstrom N, Horn SD, Smout RJ, Bender SA, Ferguson ML, Taler G, Sauer AC, Sharkey SS, Voss AC. The national pressure ulcer long-term care study: outcomes of pressure ulcer treatments in long-term care. J Am Geriatr Soc 2005;53:1721–9.
5. Bluestein D, Javaheri A. Pressure ulcers: prevention, evaluation, and management. Am Fam Physician 2008;78:1186–94.
6. Staas WE Jr, Cioschi HM. Pressure sores – a multifaceted approach to prevention and treatment. West J Med 1991;154:539–44.
7. Deloach ED, DiBenedetto RJ, Womble L, Gilley JD. The treatment of osteomyelitis underlying pressure ulcers. Decubitus 1992;5:32–41.
8. McInnes E, Bell-Syer SEM, Dumville JC, Legood R, Cullum NA. Support surfaces for pressure ulcer prevention. Cochrane Database Syst Rev 2008;4:CD001735.
9. Werdin F, Tenenhaus M, Rennekampff H-O. Chronic wound care. Lancet 372:1860-2.
10. Montes R, Puy C, Molina E, Hermida J. Is EPCR a multi-ligand receptor? Pros and cons. Thromb Haemost 2012;107:815–26.
11. Montes R, Díez J, Hermida J. Activated protein C: reasons to believe. J Thromb Haemost 2012;10:1733–5.
12. Jackson CJ, Xue M. Activated protein C – an anticoagulant that does more than stop clots. Int J Biochem Cell Biol 2008;40:2692–7.
13. Whitmont K, McKelvey KJ, Fulcher G, Reid ML, Xue M, Cooper A, Jackson CJ. Treatment of chronic diabetic lower leg ulcers with activated protein C: a randomised placebo-controlled, double-blind pilot clinical trial. Int Wound J 2013; [Epub 2013/07/15]; doi: 10.1111/iwj.12125
14. Whitmont K, Reid I, Tritton S, March L, Xue M, Lee M, Fulcher G, Sambrook P, Slobedman E, Cooper A, Jackson C. Treatment of chronic leg ulcers with topical activated protein C. Arch Dermatol 2008;144:1479–83.
15. Wijewardena A, Vandervord E, Lajevardi SS, Vandervord J, Jackson CJ. Combination of activated protein C and topical negative pressure rapidly regenerates granulation tissue over exposed bone to heal recal-citrant orthopedic wounds. Int J Low Extrem Wounds 2011;10:146–51.
16. Ubbink Dirk T, Westerbos Stijn J, Evans D, Land L, Vermeulen H. Topical negative pressure for treating chronic wounds. Cochrane Database Syst Rev 2008;3:CD001898.
17. Thompson JT, Marks MW. Negative pressure wound therapy. Clin Plast Surg 2007;34:673–84.
18. Kim PJ, Attinger CE, Steinberg JS, Evans KK, Lehner B, Willy C, Lav-ery L, Wolvos T, Orgill D, Ennis W, Lantis J, Gabriel A, Schultz G. Negative pressure wound therapy with instillation: consensus guide-lines. Plast Reconstr Surg 2013;132:1569–79.
19. Gupta S, Baharestani M, Baranoski S, de Leon J, Engel SJ, Mendez-Eastman S, Niezgoda JA, Pompeo MQ. Guidelines for managing pressure ulcers with negative pressure wound therapy. Adv Skin Wound Care 2004;17(2 Suppl):1–16.
20. McInnes E, Dumville JC, Jammali-Blasi A, Bell-Syer SE. Support surfaces for treating pressure ulcers. Cochrane Database Syst Rev 2011;12:CD009490.
21. Bergstrom N, Braden BJ, Laguzza A, Holman V. The Braden scale for predicting pressure sore risk. Nurs Res 1987;36:205–10.
22. Bloomfield SA. Changes in musculoskeletal structure and function with prolonged bed rest. Med Sci Sports Exerc 1997;29:197–206.
23. Campbell AJ, Borrie MJ, Spears GF. Risk factors for falls in a community-based prospective study of people 70 years and older. J Gerontol 1989;44:M112–7.
24. Brower RG. Consequences of bed rest. Crit Care Med 2009;37:S422–8.
25. Julovi SM, Xue M, Dervish S, Sambrook PN, March L, Jackson CJ. Protease activated receptor-2 mediates activated protein C-induced cutaneous wound healing via inhibition of p38. Am J Pathol 2011;179:2233–42.